MBS6002855 | Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) (FITC)

Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) (FITC) | MBS6002855 | MyBiosource

Product Short Name: [Renal Cell Carcinoma, gp200-MR6]

Product Name Synonyme: [Anti -Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) (FITC)]

Other Names: N/A

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: N/A

Clonality: Monoclonal

Isotype: IgG2a

Clone: [10B1029]

Host: Rat

Reactivity: Mouse

Specificity: Recognizes mouse CD205 (DEC-205).

Purity: Affinity Purified
Purified by Protein G affinity chromatography.

Form: Supplied as a liquid in PBS, pH 7.4, 1% BSA, 0.09% sodium azide. Labeled with fluorescein isothiocyanate (FITC).

Concentration: N/A

Storage Stability: May be stored at 4 degree C for short-term only. For long-term storage and to avoid repeated freezing and thawing, add sterile 40-50% glycerol, aliquot and store at -20 degree C. Aliquots are stable for at least 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. FITC conjugates are sensitive to light.

Tested Application: Flow Cytometry (FC/FACS)